G0537
Risk ascvd tst once pr 12 mo
Behavioral therapy for atherosclerotic cardiovascular disease risk assessment, up to 15 minutes. CMS 2026 wRVU 0.18. Implemented in 2025; pairs naturally with the AWV. Once per 12 months per beneficiary.
When to use it
G0537 captures an annual ASCVD risk calculation plus counseling for patients without established atherosclerotic cardiovascular disease. Use the ACC/AHA Pooled Cohort Equations (PCE) or an equivalent validated tool to compute the 10-year ASCVD risk percentage.
Full guidance
The code is for primary prevention only: patients with known coronary artery disease, prior MI, prior stroke, peripheral artery disease, or any documented ASCVD do not qualify. Most natural pairing is with G0438 or G0439 (AWV), but G0537 can also be billed at a problem-oriented visit. Counseling must address one or more modifiable risk factors: hypertension, dyslipidemia, smoking, diabetes, weight, physical activity, or diet. Once per 12 months. ICD-10: Z13.6 (cardiovascular disorder screening). G0538 is the same-day add-on for additional 15-minute increments of high-intensity behavioral counseling (rarely used in primary care; more relevant in cardiology or weight-management practices).
Documentation checklist
- ✓Calculated ASCVD risk percentage using the ACC/AHA Pooled Cohort Equations or an equivalent (Reynolds, MESA). Document the actual percentage, not just a qualitative risk band.
- ✓Time spent on the assessment and counseling: 5 to 15 minutes, documented separately from E/M time on the same date.
- ✓Counseling content: at least one modifiable risk factor discussed and a brief lifestyle plan documented (e.g., "discussed Mediterranean diet, recommended 150 minutes per week of moderate-intensity physical activity").
- ✓Patient does not have established ASCVD: no active ICD-10 codes I20-I25 (ischemic heart disease), I63 (cerebral infarction), I65-I66 (cerebrovascular disease), I70-I75 (peripheral artery disease), or G45 (TIA).
- ✓Annual frequency only; confirm that the prior G0537 was more than 365 days ago.
- ✓Z13.6 (cardiovascular disorder screening) on the claim.
- ✓If billed on the same day as G0438 or G0439, no special modifier is needed; the AWV does not absorb the ASCVD assessment work.
Common pitfalls
- !Billing G0537 in a patient with established ASCVD. The code is for primary prevention only; patients with I20-I25, I63, I65-I66, I70-I75, or G45 are excluded. Statin-naive secondary-prevention patients still do not qualify.
- !Documenting "high cardiovascular risk" without a calculated PCE percentage. The numeric risk score is the structural deliverable; without it, the code is indefensible at audit.
- !Billing more than once per 12 months. Annual frequency only, per beneficiary.
- !Counseling that does not reference any modifiable risk factor. "Discussed cardiovascular health" is insufficient. Name the factor: tobacco cessation, Mediterranean diet, 150 minutes per week of activity, weight reduction, or specific blood-pressure or lipid targets.
- !Confusing G0537 with statin therapy initiation E/M. The pharmacologic decision is part of your E/M, not the G0537 work. G0537 is the risk-assessment-plus-lifestyle counseling component.
- !Forgetting to add G0537 at AWV days. Estimated eligibility is high in primary care, observed capture is well under 20 percent nationally. One of the most under-coded preventive services.
Payer notes
Medicare implemented G0537 in 2025 and covers it with no patient cost share when billed preventively. Medicare Advantage plans typically follow Medicare rules. Commercial payer coverage is mixed; many do not yet recognize G0537 and expect risk assessment to be embedded inside a preventive E/M. Verify payer-specific coverage before billing commercial. Payers that accept G0537 audit for the actual calculated percentage; a qualitative high, medium, or low rating is not enough.